Cargando…

Iron profile of pregnant sickle cell anemia patients in Odisha, India

INTRODUCTION: During pregnancy, the iron requirement increases to meet the optimal growth of the fetus and prevent iron deficiency anemia-related complications in the mother. However, in sickle cell disease (SCD) primarily due to repeated blood transfusions and hemolysis-induced recycling of iron, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukla, Sunil Kumar, Mohanty, Pradeep Kumar, Patel, Siris, Das, Kishalaya, Hiregoudar, Mrutyunjay, Soren, Uttam Kumar, Meher, Satyabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433298/
https://www.ncbi.nlm.nih.gov/pubmed/35216958
http://dx.doi.org/10.1016/j.htct.2021.06.012
_version_ 1785091618649407488
author Sukla, Sunil Kumar
Mohanty, Pradeep Kumar
Patel, Siris
Das, Kishalaya
Hiregoudar, Mrutyunjay
Soren, Uttam Kumar
Meher, Satyabrata
author_facet Sukla, Sunil Kumar
Mohanty, Pradeep Kumar
Patel, Siris
Das, Kishalaya
Hiregoudar, Mrutyunjay
Soren, Uttam Kumar
Meher, Satyabrata
author_sort Sukla, Sunil Kumar
collection PubMed
description INTRODUCTION: During pregnancy, the iron requirement increases to meet the optimal growth of the fetus and prevent iron deficiency anemia-related complications in the mother. However, in sickle cell disease (SCD) primarily due to repeated blood transfusions and hemolysis-induced recycling of iron, its supplementation during pregnancy remains questionable and may be harmful. METHODS: Twenty-five pregnant women with homozygous SCD and 25 pregnant women with normal hemoglobin variants were included as cases and control, respectively. Pregnancy and sickle cell anemia (SCA) were diagnosed using standard protocols. The serum iron, serum ferritin, total iron-binding capacity (TIBC), percentage transferrin saturation and C-reactive protein were estimated, as per the manufacturer's protocol. The complete blood count was performed. The unpaired ‘t-test’ was performed using the SPSS v23.0 and the principal component analysis (PCA) was performed using the online software MetaboAnalyst for statistical analysis. MAIN RESULTS: The studied cases had significantly lower mean hemoglobin and higher mean corpuscular volume (MCV), compared to controls. The mean serum-iron, serum-ferritin and percentage transferrin-saturation in the cases were significantly higher than that of the controls, while the TIBC was lower in the cases (p < 0.0001). The mean level of serum iron, ferritin, percentage transferrin saturation and TIBC were 309.44 ± 122.40mcg/dl, 860.36 ± 624.64ng/ml, 42.6 ± 17.30% and 241.32 ± 96.30 mcg/dl, respectively, in the cases and 95.36 ± 41.90mcg/dl, 122.28 ± 49.70ng/ml, 15.83 ± 3.10% and 492.6 ± 149.40mcg/dl in the controls, respectively. Higher MCV, mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) with lower hemoglobin (Hb) were noted in the cases. The PCA revealed that the cases were more heterogeneous in terms of the variability of the iron status and hematological indices than the controls. CONCLUSION: The current study shows iron sufficiency in most cases of pregnancy with SCA and suggests that evaluation of iron status must be made before initiating iron prophylaxis in pregnant women with SCA, especially in regions having a high prevalence of sickle cell hemoglobinopathy.
format Online
Article
Text
id pubmed-10433298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-104332982023-08-18 Iron profile of pregnant sickle cell anemia patients in Odisha, India Sukla, Sunil Kumar Mohanty, Pradeep Kumar Patel, Siris Das, Kishalaya Hiregoudar, Mrutyunjay Soren, Uttam Kumar Meher, Satyabrata Hematol Transfus Cell Ther Original Article INTRODUCTION: During pregnancy, the iron requirement increases to meet the optimal growth of the fetus and prevent iron deficiency anemia-related complications in the mother. However, in sickle cell disease (SCD) primarily due to repeated blood transfusions and hemolysis-induced recycling of iron, its supplementation during pregnancy remains questionable and may be harmful. METHODS: Twenty-five pregnant women with homozygous SCD and 25 pregnant women with normal hemoglobin variants were included as cases and control, respectively. Pregnancy and sickle cell anemia (SCA) were diagnosed using standard protocols. The serum iron, serum ferritin, total iron-binding capacity (TIBC), percentage transferrin saturation and C-reactive protein were estimated, as per the manufacturer's protocol. The complete blood count was performed. The unpaired ‘t-test’ was performed using the SPSS v23.0 and the principal component analysis (PCA) was performed using the online software MetaboAnalyst for statistical analysis. MAIN RESULTS: The studied cases had significantly lower mean hemoglobin and higher mean corpuscular volume (MCV), compared to controls. The mean serum-iron, serum-ferritin and percentage transferrin-saturation in the cases were significantly higher than that of the controls, while the TIBC was lower in the cases (p < 0.0001). The mean level of serum iron, ferritin, percentage transferrin saturation and TIBC were 309.44 ± 122.40mcg/dl, 860.36 ± 624.64ng/ml, 42.6 ± 17.30% and 241.32 ± 96.30 mcg/dl, respectively, in the cases and 95.36 ± 41.90mcg/dl, 122.28 ± 49.70ng/ml, 15.83 ± 3.10% and 492.6 ± 149.40mcg/dl in the controls, respectively. Higher MCV, mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) with lower hemoglobin (Hb) were noted in the cases. The PCA revealed that the cases were more heterogeneous in terms of the variability of the iron status and hematological indices than the controls. CONCLUSION: The current study shows iron sufficiency in most cases of pregnancy with SCA and suggests that evaluation of iron status must be made before initiating iron prophylaxis in pregnant women with SCA, especially in regions having a high prevalence of sickle cell hemoglobinopathy. Sociedade Brasileira de Hematologia e Hemoterapia 2023-07 2021-09-11 /pmc/articles/PMC10433298/ /pubmed/35216958 http://dx.doi.org/10.1016/j.htct.2021.06.012 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Sukla, Sunil Kumar
Mohanty, Pradeep Kumar
Patel, Siris
Das, Kishalaya
Hiregoudar, Mrutyunjay
Soren, Uttam Kumar
Meher, Satyabrata
Iron profile of pregnant sickle cell anemia patients in Odisha, India
title Iron profile of pregnant sickle cell anemia patients in Odisha, India
title_full Iron profile of pregnant sickle cell anemia patients in Odisha, India
title_fullStr Iron profile of pregnant sickle cell anemia patients in Odisha, India
title_full_unstemmed Iron profile of pregnant sickle cell anemia patients in Odisha, India
title_short Iron profile of pregnant sickle cell anemia patients in Odisha, India
title_sort iron profile of pregnant sickle cell anemia patients in odisha, india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433298/
https://www.ncbi.nlm.nih.gov/pubmed/35216958
http://dx.doi.org/10.1016/j.htct.2021.06.012
work_keys_str_mv AT suklasunilkumar ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT mohantypradeepkumar ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT patelsiris ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT daskishalaya ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT hiregoudarmrutyunjay ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT sorenuttamkumar ironprofileofpregnantsicklecellanemiapatientsinodishaindia
AT mehersatyabrata ironprofileofpregnantsicklecellanemiapatientsinodishaindia